Biogen teams up with Amicus on Parkinson’s disease treatments

Biogen Idec has solidified yet another deal, this time with Amicus Therapeutics. The Weston, Mass. biotech has sealed a collaboration deal with Amicus (Nasdaq: FOLD) on the identification, development and commercialization of Parkinson’s disease treatments...